Sibren M. Van Den Berg
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Medicine Development and Access for Rare Diseases: Can We Do Better?
Journal: Journal of inherited metabolic disease
Published: August 02, 2025
Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix.
Journal: Orphanet journal of rare diseases
Published: September 30, 2024
Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 26, 2024
Application of four pricing models for orphan medicines: a case study for lumasiran.
Journal: Orphanet journal of rare diseases
Published: June 17, 2024
Reliable business case for repurposing of existing medicines requires key changes in government policies.
Journal: Drug discovery today
Published: June 06, 2024
Drug pricing models, no 'one-size-fits-all' approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: May 31, 2024
Medicine compounding in the pharmacy
Journal: Nederlands tijdschrift voor geneeskunde
Published: March 17, 2023
Access to medicines for rare diseases: A European regulatory roadmap for academia.
Journal: Frontiers in pharmacology
Published: January 11, 2023
Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public-private partnerships.
Journal: Journal of inherited metabolic disease
Published: December 23, 2022
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: March 15, 2022
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi).
Journal: Orphanet journal of rare diseases
Published: November 23, 2021
Last Updated: 09/26/2026